| Psychosis |
0 |
1 |
| Depression |
0 |
0.85 |
| Schizophrenia |
0 |
0.38 |
| Intravenous |
0 |
0.28 |
| Adverse Effects |
0 |
0.6 |
| Antidepressant drug |
0 |
0.14 |
| Clinical Research |
0 |
0.95 |
| New York |
0 |
0.14 |
| Patient History |
0 |
0.14 |
| Patient Safety |
0 |
0.5 |
| Health Care Reform |
0 |
0.11 |
| Electroconvulsive Therapy |
0 |
0.07 |
| Hallucination |
0 |
0.07 |
| Health Care Quality, Access, and Evaluation |
0 |
0.07 |
| Major Depression |
0 |
0.07 |
| Meta-Analysis |
0 |
0.07 |
| Outpatient Clinic |
0 |
0.07 |
| Psychotherapy |
0 |
0.07 |
| Schizoaffective Disorder |
0 |
0.07 |
| Social Determinants of Health |
0 |
0.06 |